Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
45
MET Quote, Financials, Valuation and Earnings
Last price:
$77.30
Seasonality move
:
0.97%
Day range:
$76.14 - $77.58
52-week range:
$65.21 - $87.39
Dividend yield:
2.94%
P/E ratio:
16.41x
P/S ratio:
0.68x
P/B ratio:
1.78x
Volume:
3.1M
Avg. volume:
3.9M
1-year change:
-6.11%
Market cap:
$50.7B
Revenue:
$77.1B
EPS (TTM):
$4.71
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $69.7B | $68.8B | $66.9B | $71B | $77.1B | |
| Revenue Growth (YoY) | 2.71% | -1.31% | -2.71% | 6.1% | 8.59% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $545M | $520M | $297M | $356M | -- | |
| Operating Expenses | -$7.6B | -$7.3B | -$3.2B | -$6.7B | -$5.7B | |
| Operating Income | $7.6B | $7.3B | $3.2B | $6.7B | $5.7B | |
| Net Interest Expenses | $920M | $938M | $1B | $1B | $1.1B | |
| EBT. Incl. Unusual Items | $8.1B | $6.4B | $2.2B | $5.6B | $4.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.6B | $1.1B | $560M | $1.2B | $1.3B | |
| Net Income to Company | $6.9B | $5.3B | $1.6B | $4.4B | -- | |
| Minority Interest in Earnings | $21M | $18M | $24M | $18M | $24M | |
| Net Income to Common Excl Extra Items | $6.6B | $5.3B | $1.6B | $4.4B | $3.4B | |
| Basic EPS (Cont. Ops) | $7.36 | $6.35 | $1.82 | $5.98 | $4.82 | |
| Diluted EPS (Cont. Ops) | $7.31 | $6.30 | $1.81 | $5.94 | $4.71 | |
| Weighted Average Basic Share | $862.7M | $803.2M | $757.7M | $706.4M | $658.1M | |
| Weighted Average Diluted Share | $869.4M | $808.9M | $762.3M | $711.1M | $673.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $8.1B | $6.4B | $2.2B | $5.6B | $4.7B | |
| Revenue (Reported) | $69.7B | $68.8B | $66.9B | $71B | $77.1B | |
| Operating Income (Reported) | $7.6B | $7.3B | $3.2B | $6.7B | $5.7B | |
| Operating Income (Adjusted) | $8.1B | $6.4B | $2.2B | $5.6B | $4.7B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20.1B | $15.6B | $19B | $18.7B | $23.8B | |
| Revenue Growth (YoY) | 3.46% | -22.31% | 21.91% | -1.9% | 27.58% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $132M | $103M | $93M | $85M | -- | |
| Operating Expenses | -$1.5B | -$2.3B | -$1.2B | -$1.6B | -$1.4B | |
| Operating Income | $1.5B | $2.3B | $1.2B | $1.6B | $1.4B | |
| Net Interest Expenses | $224M | $248M | $269M | $259M | $263M | |
| EBT. Incl. Unusual Items | $1.3B | $2B | $941M | $1.4B | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $95M | $445M | $327M | $106M | $301M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $6M | $3M | $7M | $4M | $7M | |
| Net Income to Common Excl Extra Items | $1.2B | $1.6B | $614M | $1.3B | $816M | |
| Basic EPS (Cont. Ops) | $1.42 | $1.97 | $0.79 | $1.80 | $1.18 | |
| Diluted EPS (Cont. Ops) | $1.39 | $1.96 | $0.77 | $1.78 | $1.17 | |
| Weighted Average Basic Share | $827.6M | $786.3M | $730.8M | $689.2M | $658.1M | |
| Weighted Average Diluted Share | $845.2M | $790.2M | $743.4M | $697.9M | $662.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.3B | $2B | $941M | $1.4B | $1.1B | |
| Revenue (Reported) | $20.1B | $15.6B | $19B | $18.7B | $23.8B | |
| Operating Income (Reported) | $1.5B | $2.3B | $1.2B | $1.6B | $1.4B | |
| Operating Income (Adjusted) | $1.3B | $2B | $941M | $1.4B | $1.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $71.1B | $68.8B | $66.9B | $71B | $77.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.1B | $520M | $297M | $356M | -- | |
| Operating Expenses | -$9B | -$7.3B | -$3.2B | -$6.7B | -$5.7B | |
| Operating Income | $9B | $7.3B | $3.2B | $6.7B | $5.7B | |
| Net Interest Expenses | $920M | $938M | $1B | $1B | $1.1B | |
| EBT. Incl. Unusual Items | $8.1B | $6.4B | $2.2B | $5.6B | $4.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.6B | $1.1B | $560M | $1.2B | $1.3B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $21M | $18M | $24M | $18M | $24M | |
| Net Income to Common Excl Extra Items | $6.6B | $5.3B | $1.6B | $4.4B | $3.4B | |
| Basic EPS (Cont. Ops) | $7.38 | $6.34 | $1.85 | $6.01 | $4.74 | |
| Diluted EPS (Cont. Ops) | $7.31 | $6.30 | $1.83 | $5.96 | $4.71 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $8.1B | $6.4B | $2.2B | $5.6B | $4.7B | |
| Revenue (Reported) | $71.1B | $68.8B | $66.9B | $71B | $77.1B | |
| Operating Income (Reported) | $9B | $7.3B | $3.2B | $6.7B | $5.7B | |
| Operating Income (Adjusted) | $8.1B | $6.4B | $2.2B | $5.6B | $4.7B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $68.8B | $66.9B | $71B | $77.1B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $520M | $297M | $356M | $151M | -- | |
| Operating Expenses | -$7.3B | -$3.2B | -$6.7B | -$5.7B | -- | |
| Operating Income | $7.3B | $3.2B | $6.7B | $5.7B | -- | |
| Net Interest Expenses | $938M | $1B | $1B | $1.1B | -- | |
| EBT. Incl. Unusual Items | $6.4B | $2.2B | $5.6B | $4.7B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1B | $560M | $1.2B | $1.3B | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $18M | $24M | $18M | $24M | -- | |
| Net Income to Common Excl Extra Items | $5.3B | $1.6B | $4.4B | $3.4B | -- | |
| Basic EPS (Cont. Ops) | $6.34 | $1.85 | $6.01 | $4.74 | -- | |
| Diluted EPS (Cont. Ops) | $6.30 | $1.83 | $5.96 | $4.71 | -- | |
| Weighted Average Basic Share | $3.2B | $3B | $2.8B | $2.7B | -- | |
| Weighted Average Diluted Share | $3.2B | $3B | $2.8B | $2.7B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $6.4B | $2.2B | $5.6B | $4.7B | -- | |
| Revenue (Reported) | $68.8B | $66.9B | $71B | $77.1B | -- | |
| Operating Income (Reported) | $7.3B | $3.2B | $6.7B | $5.7B | -- | |
| Operating Income (Adjusted) | $6.4B | $2.2B | $5.6B | $4.7B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $20B | $20.2B | $20.6B | $20.1B | $22B | |
| Short Term Investments | $347.5B | $281.7B | $287.5B | $80.5B | -- | |
| Accounts Receivable, Net | $17.1B | $17.4B | $29B | $29.8B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $55.4B | $54.1B | $69.1B | $69.8B | $79.1B | |
| Property Plant And Equipment | $2.7B | -- | -- | -- | -- | |
| Long-Term Investments | $32.5B | $33.7B | $32.3B | $32.2B | -- | |
| Goodwill | $9.5B | $9.3B | $9.2B | $8.9B | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $759.7B | $663.1B | $687.6B | $677.5B | $745.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $241M | $76M | $119M | $465M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $32.3B | $21.1B | $17.7B | $17.6B | $17.5B | |
| Long-Term Debt | $17.9B | $18.5B | $19.3B | $18.7B | $19B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $692B | $632.9B | $657.3B | $649.8B | $716.2B | |
| Common Stock | $12M | $12M | $12M | $12M | $12M | |
| Other Common Equity Adj | $10.9B | -$22.6B | -$19.2B | -$21.2B | -- | |
| Common Equity | $67.5B | $29.9B | $30B | $27.4B | $28.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $267M | $244M | $238M | $258M | $523M | |
| Total Equity | $67.7B | $30.1B | $30.3B | $27.7B | $28.9B | |
| Total Liabilities and Equity | $759.7B | $663.1B | $687.6B | $677.5B | $745.2B | |
| Cash and Short Terms | $367.5B | $301.9B | $308.1B | $100.6B | -- | |
| Total Debt | $17.9B | $18.5B | $19.3B | $18.7B | $19B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $20B | $20.2B | $20.6B | $20.1B | $22B | |
| Short Term Investments | $347.5B | $281.7B | $287.5B | $80.5B | -- | |
| Accounts Receivable, Net | $17.1B | $17.4B | $29B | $29.8B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $55.4B | $54.1B | $69.1B | $69.8B | $79.1B | |
| Property Plant And Equipment | $2.7B | -- | -- | -- | -- | |
| Long-Term Investments | $32.5B | $33.7B | $32.3B | $32.2B | -- | |
| Goodwill | $9.5B | $9.3B | $9.2B | $8.9B | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $759.7B | $663.1B | $687.6B | $677.5B | $745.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $241M | $76M | $119M | $465M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $32.3B | $21.1B | $17.7B | $17.6B | $17.5B | |
| Long-Term Debt | $17.9B | $18.5B | $19.3B | $18.7B | $19B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $692B | $632.9B | $657.3B | $649.8B | $716.2B | |
| Common Stock | $12M | $12M | $12M | $12M | $12M | |
| Other Common Equity Adj | $10.9B | -$22.6B | -$19.2B | -$21.2B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $267M | $244M | $238M | $258M | $523M | |
| Total Equity | $67.7B | $30.1B | $30.3B | $27.7B | $28.9B | |
| Total Liabilities and Equity | $759.7B | $663.1B | $687.6B | $677.5B | $745.2B | |
| Cash and Short Terms | $367.5B | $301.9B | $308.1B | $100.6B | -- | |
| Total Debt | $17.9B | $18.5B | $19.3B | $18.7B | $19B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.9B | $5.3B | $1.6B | $4.4B | -- | |
| Depreciation & Amoritzation | $694M | $673M | $718M | $714M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $362M | $299M | -$2B | $460M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $12.8B | $11.4B | $14.3B | $15.1B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$11.2B | -$2.6B | -$10.2B | -$11.5B | -- | |
| Dividends Paid (Ex Special Dividend) | $1.8B | $1.8B | $1.8B | $1.7B | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $29M | $1B | $2.7B | $1.9B | -- | |
| Long-Term Debt Repaid | -$582M | -$85M | -$1.9B | -$2.7B | -- | |
| Repurchase of Common Stock | $4.8B | $3.3B | $3.1B | $3.2B | -- | |
| Other Financing Activities | $4.2B | $5B | $4.4B | $2.9B | -- | |
| Cash From Financing | -$1.4B | -$9.9B | -$2.9B | -$3.1B | -- | |
| Beginning Cash (CF) | $20B | $20.2B | $20.6B | $20.1B | $22B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$213M | -$1.6B | $983M | -$53M | -- | |
| Ending Cash (CF) | $19.4B | $18.2B | $21.5B | $19.5B | -- | |
| Levered Free Cash Flow | $12.8B | $11.4B | $14.3B | $15.1B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.6B | $630M | $5.7B | $5.1B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.9B | -$197M | $576M | -$5.4B | -- | |
| Dividends Paid (Ex Special Dividend) | $434M | $422M | $419M | $410M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $328M | $159M | -- | |
| Long-Term Debt Repaid | -$42M | -$8M | -$128M | -$354M | -- | |
| Repurchase of Common Stock | $1.2B | $596M | $859M | $406M | -- | |
| Other Financing Activities | -$38M | $686M | $1.3B | $342M | -- | |
| Cash From Financing | -$1.3B | -$4.5B | -$176M | -$519M | -- | |
| Beginning Cash (CF) | $20B | $20.2B | $20.6B | $20.1B | $22B | |
| Foreign Exchange Rate Adjustment | -$86M | $359M | $145M | -$425M | -- | |
| Additions / Reductions | $1.3B | -$3.7B | $6.3B | -$1.2B | -- | |
| Ending Cash (CF) | $21.2B | $16.9B | $27.1B | $18.5B | -- | |
| Levered Free Cash Flow | $5.6B | $630M | $5.7B | $5.1B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $12.8B | $11.4B | $14.3B | $15.1B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$11.2B | -$2.6B | -$10.2B | -$11.5B | -- | |
| Dividends Paid (Ex Special Dividend) | $1.8B | $1.8B | $1.8B | $1.7B | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1B | $2.7B | $1.9B | -- | |
| Long-Term Debt Repaid | -$582M | -$85M | -$1.9B | -$2.7B | -- | |
| Repurchase of Common Stock | $4.8B | $3.3B | $3.1B | $3.2B | -- | |
| Other Financing Activities | $4.2B | $5B | $4.4B | $2.9B | -- | |
| Cash From Financing | -$1.4B | -$9.9B | -$2.9B | -$3.1B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$213M | -$1.6B | $983M | -$53M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $12.8B | $11.4B | $14.3B | $15.1B | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.4B | $14.3B | $15.1B | $10B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.6B | -$10.2B | -$11.5B | -$11.3B | -- | |
| Dividends Paid (Ex Special Dividend) | $1.8B | $1.8B | $1.7B | $1.3B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1B | $2.7B | $1.9B | $2B | -- | |
| Long-Term Debt Repaid | -$85M | -$1.9B | -$2.7B | -$1.2B | -- | |
| Repurchase of Common Stock | $3.3B | $3.1B | $3.2B | $3.4B | -- | |
| Other Financing Activities | $5B | $4.4B | $2.9B | $3.7B | -- | |
| Cash From Financing | -$9.9B | -$2.9B | -$3.1B | $1.2B | -- | |
| Beginning Cash (CF) | $86.4B | $69.4B | $82.5B | $85.8B | -- | |
| Foreign Exchange Rate Adjustment | -$397M | -$91M | -$545M | $309M | -- | |
| Additions / Reductions | -$1.6B | $983M | -$53M | $165M | -- | |
| Ending Cash (CF) | $84.4B | $70.3B | $81.9B | $64.2B | -- | |
| Levered Free Cash Flow | $11.4B | $14.3B | $15.1B | $10B | -- | |
Get MET Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MET
Sector
P/E ratio
16.41x
12.49x
PEG ratio
2.06x
0.32x
P/B ratio
1.78x
1.14x
Price / LTM sales
0.68x
1.85x
Growth Metrics
MET
Sector
Revenue growth
27.58%
5.46%
Earnings growth
-33.82%
10.33%
Revenue (5-year growth)
2.59%
8.67%
Earnings forecast
$2.34
$0.64
Profitability
MET
Sector
Profitability FY 2025
--
--
Return on invested capital
7.08%
5.19%
Return on assets
0.48%
1.03%
Return on equity
12.03%
9.9%
Earnings Date
Last Earnings Date
Feb
4
Next Earnings Date
Apr
29
Estimated Next Earnings Date
May
6
Balance Sheet
MET
Sector
Total cash
$112.7B
$406.5M
Short term investments
$80.5B
$190.5M
Total assets
$745.2B
$3.1B
Long term debt
$19B
$55.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
